Bayer Aktiengesellschaft

Troponwerke Gmbh & Co Kg

Hans-Georg Opitz

Oswald Lockhoff

Peter Stadler

Karl G Metzger

Hans-Joachim Zeiler

Bernd-Wieland Kruger

Klaus Schaller

Klaus G Stunkel

Bodo Junge

Harald Horstmann

Bernhard Pelster

Compounds of the formula ##STR1## wherein R.sup.1 is hydrogen, an optionally substituted aromatic hydrocarbon radical, an aralkyl radical or an optionally substituted aliphatic hydrocarbon radical having up to 45 C atoms,

Immune system-stimulating N-glycosylated ureas and carbamates

Compounds of the formula ##STR1## in which X is hydrogen or the radical CH.sub.2 OR.sup.5,

Pharmaceutical use of substituted O-acylglycosides

A method of combating rheumatic diseases which comprises administering to a patient afflicted therewith an amount effective to combat such disease of a compound of the formula ##STR1## in which Z is a glycosyl radical bonded via the anomeric carbon atom,

N-glycosylated carboxylic acid derivatives as agents for combating

The invention relates to N-glycosylated carboxamide derivatives of Formula I which are useful for influencing the body's inherent defenses, e.g. for increasing immune system antibodies. Also included in the invention are compositions containing said N-glycosylated carboxamide derivative of Formula I as active ingredients and methods for the use of said compounds and compositions.

N-glycosylated carboxamide derivatives and their use for influencing the

Compounds of the formula ##STR1## in which X is hydrogen or the radical --CH.sub.2 OR.sup.5,

Substituted O-acylglycosylamides, pharmaceutical compositions and method

The invention concerns MASF (mercapto-activatable serum factor) activated by a mercapto compound. Also included in the invention are processes for the preparation of said activated MASF, compositions containing said activated MASF and methods for the use of said activated MASF.

Growing community of inventors

Emeryville, CA, United States of America

Hans-Georg Opitz